{"id":"https://openalex.org/W2585217794","doi":"https://doi.org/10.1182/blood.v120.21.4721.4721","title":"BTK inhibitor PCI-32765 targets endogenous and microenvironment-mediated B-cell receptor signaling to suppress lymphoma cell growth and is highly synergistic with Bortezmib against non-Hodgkin B-cell lymphomas","display_name":"BTK inhibitor PCI-32765 targets endogenous and microenvironment-mediated B-cell receptor signaling to suppress lymphoma cell growth and is highly synergistic with Bortezmib against non-Hodgkin B-cell lymphomas","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2585217794","doi":"https://doi.org/10.1182/blood.v120.21.4721.4721","mag":"2585217794"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.4721.4721","doi":"https://doi.org/10.1182/blood.v120.21.4721.4721","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.4721.4721","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100640261","display_name":"Bing Xia","orcid":"https://orcid.org/0000-0003-3297-5702","observed_orcids":["https://orcid.org/0000-0003-3297-5702"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Bing Xia","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100683747","display_name":"Xiaowu Li","orcid":"https://orcid.org/0000-0002-8221-7064","observed_orcids":["https://orcid.org/0000-0002-8221-7064"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xiaowu Li","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100717197","display_name":"Le Zhang","orcid":"https://orcid.org/0000-0002-5276-6468","observed_orcids":["https://orcid.org/0000-0002-5276-6468"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Le Zhang","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qing Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qing Guo","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xin Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xin Jin","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034794859","display_name":"Shanqi Guo","orcid":"https://orcid.org/0000-0002-8385-4567","observed_orcids":["https://orcid.org/0000-0002-8385-4567"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Shanqi Guo","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108222207","display_name":"Eduardo M. Sotomayor","orcid":"https://orcid.org/0009-0009-5081-3855","observed_orcids":["https://orcid.org/0009-0009-5081-3855"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eduardo M. Sotomayor","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101721787","display_name":"Yizhuo Zhang","orcid":"https://orcid.org/0000-0002-1529-6671","observed_orcids":["https://orcid.org/0000-0002-1529-6671"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yizhuo Zhang","raw_affiliation_strings":["Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of hematology and blood and marrow transplantation of Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China,","institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034794859","https://openalex.org/A5100640261","https://openalex.org/A5100683747","https://openalex.org/A5100717197","https://openalex.org/A5101721787"],"corresponding_institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I5740404"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.37622726,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":"21","first_page":"4721","last_page":"4721"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8755000233650208,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8755000233650208,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.12319999933242798,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.9240000247955322},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8960000276565552},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8040000200271606},{"id":"https://openalex.org/keywords/microenvironment","display_name":"microenvironment","score":0.4959999918937683},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.621999979019165},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.859000027179718},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6769999861717224},{"id":"https://openalex.org/keywords/raji","display_name":"Raji","score":0.925000011920929},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.6389999985694885},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5}],"concepts":[{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.8832002878189087},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7026129364967346},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6527065634727478},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5566999316215515},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5352901220321655},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4609085023403168},{"id":"https://openalex.org/C157695867","wikidata":"https://www.wikidata.org/wiki/Q1100474","display_name":"B-cell receptor","level":4,"score":0.4321656823158264},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.42795345187187195},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.42705225944519043},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.40760648250579834},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33599650859832764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32038551568984985},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3172417879104614},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.27023959159851074},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.22907915711402893},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.14888548851013184},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.09837937355041504},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.09648820757865906},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.4721.4721","doi":"https://doi.org/10.1182/blood.v120.21.4721.4721","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.4721.4721","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2548523404","https://openalex.org/W2588418776","https://openalex.org/W2077190302","https://openalex.org/W2326647268","https://openalex.org/W2075875145","https://openalex.org/W2584004761","https://openalex.org/W2586195647","https://openalex.org/W2551641450","https://openalex.org/W19428698","https://openalex.org/W2191804597"],"abstract_inverted_index":{"Abstract":[0,1],"4721":[2],"Background:":[3],"B-cell":[4,16,49,112,388,397],"receptor":[5],"(BCR)":[6],"signaling":[7,26,175,263],"is":[8,22],"a":[9,30,43,98,246,311,369,424],"critical":[10],"pathway":[11],"in":[12,73,84,101,104,156,243,264,287,317,333,356,387,407],"the":[13,69,80,150,157,223,239,281,350,382],"pathogenesis":[14],"of":[15,71,82,161,201,226,258,266,283,291,315,345,352,385,434],"malignancies":[17],"and":[18,27,32,56,77,91,122,129,170,173,181,184,207,216,228,234,256,260,270,285,295,347,392,405,421],"Bruton":[19],"tyrosine":[20],"kinase(Btk)":[21],"essential":[23],"for":[24,108,149,245,418,428],"BCR":[25,420],"function.":[28],"PCI-32765,":[29],"specific":[31],"irreversible":[33],"small-molecule":[34],"Btk":[35,72,172,259,284,386,422],"inhibitor,":[36],"has":[37],"recently":[38],"been":[39],"reported":[40],"to":[41,66,93,436],"display":[42],"significant":[44,312,331],"clinical":[45],"activity":[46],"against":[47,372],"non-Hodgkin":[48],"lymphomas":[50],"(NHL)":[51],"especially":[52],"chronic":[53],"lymphocytic":[54,58],"leukemia":[55],"small":[57],"lymphoma":[59,88,113,119,125,133,141,204,231,272,389,412],"(CLL/SLL).":[60],"In":[61,339],"this":[62],"study":[63,415],"we":[64],"set":[65],"explore":[67],"1)":[68],"role":[70,81],"NHL":[74,109,145,374],"cell":[75,89,114,118,126,132,134,205,232,268,297,302,390],"apoptosis":[76,235,332],"proliferation,":[78],"2)":[79],"BtK":[83],"bone":[85,162,401],"marrow":[86,163,402],"strom-mediated":[87],"survival":[90,398],"3)":[92],"test":[94],"if":[95],"PCI-32765":[96,195,202,227,300,309,341,365,394],"as":[97,137,139,178,187,189,324,423],"therapeutic":[99,426],"agent":[100],"single":[102],"or":[103,159,248],"combination":[105,408],"with":[106,276,299,337,366,409],"Bortezomib":[107,229,367,410],"therapy.":[110],"Methods:":[111],"lines":[115,120,269,298],"including":[116],"mantle":[117],"(Jeko-1":[121],"HBL-2),":[123],"Burkitt":[124],"line":[127,135],"(Raji)":[128],"transformed":[130],"large":[131],"(SUDHL-10)":[136],"well":[138,188],"primary":[140,271],"cells":[142,153,166,278,319,335,375,404],"from":[143],"various":[144,321],"samples":[146],"were":[147,154,193,209],"used":[148],"experiments.":[151],"These":[152],"cultured":[155],"presence":[158],"absence":[160],"mesenchymal":[164],"stromal":[165,403],"(MSC).":[167],"The":[168,199],"endogenous":[169],"MSC-induced":[171],"its":[174,190,261],"activation":[176,257],"such":[177],"BtK,":[179],"ERK1/2":[180],"AKT":[182,286,346],"expression":[183,255],"phosphorylation":[185],"status":[186],"inhibition":[191],"by":[192,196,211,326,400],"examined":[194],"Western":[197],"blot.":[198],"effects":[200],"on":[203,230],"growth":[206,233,303,391],"appotosis":[208],"analyzed":[210,237],"using":[212,238],"MTT,":[213],"DAPI":[214],"stain":[215],"flow":[217],"cytometric":[218],"annexin":[219],"V/PI":[220],"staining.":[221],"Furthermore,":[222,274],"combined":[224,364],"effect":[225],"was":[236],"CalcuSyn":[240],"software":[241],"program":[242],"search":[244],"synergistic":[247,370],"additive":[249],"effect.":[250],"Results:":[251],"We":[252,306,328],"found":[253,307,330],"constitutive":[254],"downstream":[262],"most":[265],"these":[267,288,318,334,357,373],"cells.":[273,289,358,413],"co-culture":[275],"MSC":[277],"further":[279],"enhanced":[280],"phosphoration":[282],"Incubation":[290],"Jeko-1,":[292],"Raji,":[293],"HBL-2":[294],"SUDHL-10":[296],"induced":[301,368],"inhibitory":[304],"effects.":[305],"that":[308,363],"exhibited":[310],"dose-dependent":[313],"induction":[314],"cytotoxicity":[316,371],"at":[320],"time":[322],"points":[323],"measured":[325],"MTT.":[327],"also":[329],"treated":[336],"PCI-32765.":[338],"addition,":[340],"significantly":[342],"inhibited":[343],"phpsphorylation":[344],"Btk,":[348],"confirming":[349],"block":[351],"BCK":[353],"signal":[354],"pathways":[355],"Finally,":[359],"MTT":[360],"assays":[361],"indicated":[362],"(CI<1).":[376],"Discussion:":[377],"Our":[378],"studies":[379],"therefore":[380],"highlight":[381],"biological":[383],"significance":[384],"survival.":[393],"effectively":[395],"antagonizes":[396],"provided":[399],"synergistically":[406],"eliminates":[411],"This":[414],"provide":[416],"rational":[417],"targeting":[419],"novel":[425],"approach":[427],"NHL.":[429],"Disclosures:":[430],"No":[431],"relevant":[432],"conflicts":[433],"interest":[435],"declare.":[437]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-02-10T00:00:00"}